FAM110A
Protein FAM110A
Also known as: bA371L19.3, C20orf55, F110A_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9BQ89
- Gene
- FAM110A
- Ensembl
- ENSG00000125898
- Chromosome
- 20
- Canonical length
- 295 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Vesicles,Cytosol
OverviewNCBI Gene
Involved in mitotic spindle organization. Located in cytosol; microtubule cytoskeleton; and nucleus. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
295 residues, UniProt reviewed canonical sequence.
>Q9BQ89|FAM110A
1 MPVHTLSPGA PSAPALPCRL RTRVPGYLLR GPADGGARKP SAVERLEADK AKYVKSLHVA
61 NTRQEPVQPL LSKQPLFSPE TRRTVLTPSR RALPGPCRRP QLDLDILSSL IDLCDSPVSP
121 AEASRTPGRA EGAGRPPPAT PPRPPPSTSA VRRVDVRPLP ASPARPCPSP GPAAASSPAR
181 PPGLQRSKSD LSERFSRAAA DLERFFNFCG LDPEEARGLG VAHLARASSD IVSLAGPSAG
241 PGSSEGGCSR RSSVTVEERA RERVPYGVSV VERNARVIKW LYGLRQARES PAAEGLocalizationUniProt · AlphaFold · HPA
Whether an antibody against FAM110A can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.65
- Highest tissue expression
- 69 nTPM
Expression across tissuesHPA
Tissue
- skin: 69 nTPM
- esophagus: 38 nTPM
- spleen: 23 nTPM
- prostate: 19 nTPM
- vagina: 18 nTPM
- salivary gland: 18 nTPM
Single-cell type
- platelets: 260 nCPM
- extravillous trophoblasts: 219 nCPM
- esophageal apical cells: 96 nCPM
- megakaryocytes: 87 nCPM
- esophageal suprabasal cells: 76 nCPM
- esophageal basal cells: 60 nCPM
Immune cell
- basophil: 546 nTPM
- non-classical monocyte: 249 nTPM
- eosinophil: 164 nTPM
- intermediate monocyte: 161 nTPM
- T-reg: 43 nTPM
- myeloid DC: 36 nTPM
Brain region
- thalamus: 13 nTPM
- pons: 10 nTPM
- midbrain: 10 nTPM
- basal ganglia: 9.6 nTPM
- medulla oblongata: 7.7 nTPM
- amygdala: 7.5 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.02
- gnomAD pLI
- 0.36
- gnomAD missense Z
- 0.64
- DepMap mean gene effect
- 0.05
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of FAM110A in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads FAM110A as an antibody target. Whether an autoantibody or antibody against FAM110A could matter depends on whether native FAM110A is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
FAM110A is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label FAM110A as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...